The life sciences industry places a premium on innovation at the highest levels, whether that's in cutting-edge scientific discovery or the complex business transactions driving the industry forward today. Morrison & Foerster's Global Life Sciences Practice is comprised of corporate, transactional, intellectual property, and litigation attorneys who share the value our clients place on this marriage of scientific and business success. We bring superior technical knowledge and business experience for our clients working at the pinnacle of innovation.
We represent more than 600 life sciences companies, research institutions, and venture capital funds and investments banks that finance them. With more than 180 life sciences lawyers around the world, our fully-integrated team has the depth of practice and global reach that are critical in today’s global life sciences market.
We have cultivated a practice that, like our clients' businesses, is driven by science. We count among our practitioners 62 PhDs in relevant scientific disciplines. Our knowledge and superior experience in the pharmaceutical, biologics, diagnostics, personalized medicine, medical device, medicinal chemicals, and vaccine fields means that we understand the complex technologies at the heart of our clients' businesses.
Among our resources is one of the largest and most recognized patent practices devoted to life sciences of any full-service law firm, with attorneys who have been involved in the development of the life sciences industry for decades. With deep understanding of how patents fit into a company's larger business model and commercial strategy, our patent attorneys assist clients with developing and monetizing their patent portfolios, crafting an IP strategy that aligns with their business objectives and goals, and providing counsel to ensure our clients' remain competitive in the industry.
It's this combination of scientific prowess and the acumen of our business lawyers and litigators that sets our practice apart. Our corporate attorneys advise life sciences companies on issues involving corporate governance and formation, mergers and acquisitions, public offerings, and public and private debt and equity financing transactions. Since 2004, we have represented life sciences clients in more than 100 venture capital financings valued in total at over $1 billion and completed more than 100 public finance and M&A transactions in the life sciences sector. Our technology transactions attorneys are leaders in structuring and negotiating licensing and strategic collaboration agreements; joint ventures; manufacturing, supply and distribution agreements; marketing agreements; technology transfers; and pre-clinical and clinical trial arrangements.
Our life sciences litigators are extolled for their work on IP, product liability, employment and labor, appellate, securities, antitrust, white collar criminal defense, trade secrets, and commercial litigation matters. Aggressively defending our clients' interests, our team is among the most active litigation department in the world and is renowned in the courtroom and, whenever possible, for keeping our clients out of the courtroom.
Our practice is truly global – one of very few firms that can say that. Our life sciences team includes attorneys across the U.S., Europe, and throughout Asia. In Japan, our size and depth of practice are unparalleled by any other international law firm. We represent some of the largest and most active participants in the Japanese biotechnology, medical technology, and pharmaceutical industries, as well as counseling both Japanese and international clients on work related to emerging life sciences companies in Japan and around the world. In China, we are helping clients enter, expand within, or grow outside of the Chinese life sciences market.
MoFo is on the cutting edge of the global interplay between science and business. With our depth of technological expertise, wealth of business insight, renowned legal skill, and global presence, our attorneys are helping clients strike the balance between innovative discovery and purposeful business planning to assure their continued success.
U.S. News – Best Lawyers® Best Law Firms 2015 National: Biotechnology Law (Tier 1) San Diego: Biotechnology Law (Tier 1)
Chambers Global 2017 Global: Life Sciences Asia-Pacific Region: Life Sciences
Managing Intellectual Property World IP Survey 2014 United States: National: Bio Life Sciences
Chambers USA 2017 National: Life Sciences California: Life Sciences
Legal 500 US 2016 Life Sciences Product Liability and Mass Tort Defense: Pharmaceuticals and Medical Devices
Chambers Asia Pacific 2016 Life Sciences (International Firms): China
LMG Life Sciences 2014 Firm of the year: Patent Prosecution
M&A Advisor 2013 Healthcare/Life Sciences Deal of the Year (Over $500 Million)
Here is what they say about us:
“Solid teams in the USA and Asia offer broad expertise in transactions and IP work. Noted for its capabilities in capital markets transactions and is well known for patent matters, providing specialists for litigation and prosecution. Assists key international clients in the life sciences sector.” (Chambers Global 2017)
“Clients say cases are run efficiently, effectively, with consideration of the budget and ultimately end up in an agreeable outcome.” (Chambers USA 2017)
“Particularly well known for its outstanding IP litigation, prosecution and licensing capabilities. Also adept at handling significant transactions in the sector, including strategic alliances and M&A.” (Chambers USA 2015)
“Active in the corporate transactions space and also well known for IP work in the USA and Europe. Provides strategic advice to clients in relation to acquisitions and collaborations.” (Chambers Global 2015)
“Handles significant corporate transactions for leading life sciences clients, including M&A, strategic partnerships and IPOs. Also offers outstanding expertise in IP licensing and enforcement matters in the USA, with strong support from teams in Japan and China.” (Chambers Global 2014)
Litigation Powerhouse 2016
“Handles significant corporate transactions for leading life sciences clients, including M&A, strategic partnerships and IPOs. Also offers outstanding expertise in IP licensing and enforcement matters in the USA, with strong support from teams in Japan and China.” (Chambers Global )
Recognized by U.S. News – Best Lawyers® Best Law Firms 2015 as a Tier 1 firm in biotechnology law.
©1996-2018 Morrison & Foerster LLP. All rights reserved.